355 Altiratinib (DCC-2701): a balanced inhibitor of MET, TIE2, and VEGFR2 kinases that exhibits broad anti-tumor and anti-angiogenic activities von Flynn, D, Smith, B.D, Leary, C.B, Kaufman, M.D, Turner, B.A, Hood, M.M, Lu, W.P, Rutkoski, T.J, Samarakoon, T, Vogeti, S, Wise, S.C, Rosen, O

Volltext